Kinnate Biopharma Inc.

Kinnate Biopharma Inc.verified

KNTE

Price:

$2.65

Market Cap:

$124.99M

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinna...[Read more]

Industry

Biotechnology

IPO Date

2020-12-03

Stock Exchange

NASDAQ

Ticker

KNTE

The Enterprise Value as of November 2025 (TTM) for Kinnate Biopharma Inc. (KNTE) is 71.17M

According to Kinnate Biopharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 71.17M. This represents a change of -28.88% compared to the average of 100.07M of the last 4 quarters.

Kinnate Biopharma Inc. (KNTE) Historical Enterprise Value (quarterly & annually)

How has KNTE Enterprise Value performed in the past?

The mean historical Enterprise Value of Kinnate Biopharma Inc. over the last ten years is 936.59M. The current 71.17M Enterprise Value has changed 659.86% with respect to the historical average. Over the past ten years (40 quarters), KNTE's Enterprise Value was at its highest in in the December 2019 quarter at 1.62B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

936.59M

Median

1.01B

Minimum

56.56M

Maximum

1.68B

Kinnate Biopharma Inc. (KNTE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kinnate Biopharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 1.68B

Minimum Annual Increase = -76.79%

Minimum Annual Enterprise Value = 56.56M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202356.56M-76.79%
2022243.72M-62.88%
2021656.52M-51.87%
20201.36B-15.52%
20191.61B-4.12%

Kinnate Biopharma Inc. (KNTE) Average Enterprise Value

How has KNTE Enterprise Value performed in the past?

The current Enterprise Value of Kinnate Biopharma Inc. (KNTE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

318.93M

5-year avg

787.10M

10-year avg

936.59M

Kinnate Biopharma Inc. (KNTE) Enterprise Value vs. Peers

How is KNTE’s Enterprise Value compared to its peers?

Kinnate Biopharma Inc.’s Enterprise Value is greater than NGM Biopharmaceuticals, Inc. (69.72M), less than Graybug Vision, Inc. (115.07M), less than Decibel Therapeutics, Inc. (102.82M), less than Paratek Pharmaceuticals, Inc. (351.99M), less than Tourmaline Bio, Inc. (1.20B), less than aTyr Pharma, Inc. (87.32M), greater than RVL Pharmaceuticals plc (16.09M), less than Pardes Biosciences, Inc. (75.90M), less than Sesen Bio, Inc. (127.66M), greater than Aadi Bioscience, Inc. (-24287393.00),

Build a custom stock screener for Kinnate Biopharma Inc. (KNTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kinnate Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kinnate Biopharma Inc. (KNTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kinnate Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Kinnate Biopharma Inc.'s Enterprise Value?

What is the highest Enterprise Value for Kinnate Biopharma Inc. (KNTE)?

What is the 3-year average Enterprise Value for Kinnate Biopharma Inc. (KNTE)?

What is the 5-year average Enterprise Value for Kinnate Biopharma Inc. (KNTE)?

How does the current Enterprise Value for Kinnate Biopharma Inc. (KNTE) compare to its historical average?